CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Clinical trial NCT06433362 · UNKNOWN
Trial details
- NCT number
- NCT06433362
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-30
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.